Literature DB >> 2855466

Receptor-mediated leukaemogenesis: hypothesis revisited.

J C Neil1, R Fulton, R McFarlane, M Rigby, M Stewart, A Terry, T Tzavaras.   

Abstract

The discovery of the first example of retroviral transduction of an immunological effector molecule has led us to reconsider the possible importance of cell surface receptors of the immune system in leukaemia development. Antigen receptors on lymphoid cells not only bind external ligands but are crucial in the control of cellular proliferation. The concept of autocrine stimulation in oncogenesis is already well established and we see no reason to exclude the possibility of analogous mechanism operating through antigen receptors. At present, we are investigating the oncogenic function of the retrovirus (FeLV-T17) carrying a T-cell receptor gene (v-tcr). In addressing the general concept of oncogenesis by ligand/receptor interactions in the immune system we face the problem of the diversity and, for T-cell antigen receptors, the complex nature of receptor-ligand interaction. Nevertheless, the implications of the model encourage us to continue to search for new experimental tools and approaches to the question.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2855466      PMCID: PMC2149108     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  17 in total

1.  Correlation of leukemogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeats.

Authors:  M K Short; S A Okenquist; J Lenz
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

2.  A T cell receptor V beta segment that imparts reactivity to a class II major histocompatibility complex product.

Authors:  J W Kappler; T Wade; J White; E Kushnir; M Blackman; J Bill; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

3.  Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

Authors:  C I Bargmann; M C Hung; R A Weinberg
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

4.  Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias.

Authors:  J C Neil; D Hughes; R McFarlane; N M Wilkie; D E Onions; G Lees; O Jarrett
Journal:  Nature       Date:  1984 Apr 26-May 2       Impact factor: 49.962

5.  Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer.

Authors:  P S Ohashi; T W Mak; P Van den Elsen; Y Yanagi; Y Yoshikai; A F Calman; C Terhorst; J D Stobo; A Weiss
Journal:  Nature       Date:  1985 Aug 15-21       Impact factor: 49.962

6.  Specific antigen-Ia activation of transfected human T cells expressing murine Ti alpha beta-human T3 receptor complexes.

Authors:  T Saito; A Weiss; J Miller; M A Norcross; R N Germain
Journal:  Nature       Date:  1987 Jan 8-14       Impact factor: 49.962

7.  Retroviral transduction of T-cell antigen receptor beta-chain and myc genes.

Authors:  R Fulton; D Forrest; R McFarlane; D Onions; J C Neil
Journal:  Nature       Date:  1987 Mar 12-18       Impact factor: 49.962

8.  A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus.

Authors:  P A Chatis; C A Holland; J E Silver; T N Frederickson; N Hopkins; J W Hartley
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

9.  The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential.

Authors:  L DesGroseillers; P Jolicoeur
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

10.  A subset of T cell receptors associated with L3T4 molecules mediates C6VL leukemia cell binding of its cognate retrovirus.

Authors:  H C O'Neill; M S McGrath; J P Allison; I L Weissman
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

View more
  1 in total

1.  Pathogenesis of feline leukemia virus T17: contrasting fates of helper, v-myc, and v-tcr proviruses in secondary tumors.

Authors:  A Terry; R Fulton; M Stewart; D E Onions; J C Neil
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.